Wordt geladen...
Complement as a target in COVID-19?
There is an urgent need to develop effective therapies for COVID-19. Here, we urge immunologists and clinicians to consider the potential of targeting the complement system in these patients.
Bewaard in:
| Gepubliceerd in: | Nat Rev Immunol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7187144/ https://ncbi.nlm.nih.gov/pubmed/32327719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-020-0320-7 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|